Key result
Dysbiotic microbiome transplantation impairs cardiac contractility and promotes fibrosis, an effect reversed by healthy FMT.
Why the study?
Inflammatory bowel disease is associated with increased cardiovascular risk, but the mechanisms linking gut dysbiosis to cardiac pathology remained poorly defined.
Does transplantation of a colitis-associated dysbiotic microbiome impair cardiac function and promote cardiac fibrosis, and can healthy fecal microbiota transplantation mitigate these effects in mice?
Does transplantation of a colitis-associated dysbiotic microbiome impair cardiac function and promote cardiac fibrosis, and can healthy fecal microbiota transplantation mitigate these effects in mice?
Answers are grounded in this paper and cite their sources.
Identifies a novel gut-heart axis in preclinical models where colitis-associated gut dysbiosis drives cardiac fibrosis via epigenetic activation of Bcl11b, which can be mitigated by healthy fecal microbiota transplantation.
Inflammatory bowel disease (IBD) is associated with increased cardiovascular risk, but the mechanisms linking gut dysbiosis to cardiac pathology remain poorly defined. We investigated whether transplantation of a dysbiotic microbiome (DM) from colitic mice alters cardiac function and explored the underlying mechanisms. Germ-free mice were colonized with normal microbiomes from wild-type donors or DMs from Il10 - / - mice. Cardiac function was assessed by echocardiography, and gut microbiota and cardiac transcriptomes were analyzed by 16 S rRNA- and bulk RNA-sequencing, respectively. Chronic colitis was induced by repeated dextran sodium sulfate (DSS) administration, with or without fecal microbiota transplantation (FMT) from healthy controls. Epigenetic mechanisms were investigated using chromatin immunoprecipitation and methylation-specific qPCR. DM transplantation impaired cardiac contractility and increased collagen deposition. Cardiac RNA-seq revealed extensive transcriptional remodeling, particularly in females, with enrichment in histone acetylation and immune signaling pathways. Nat8f7 and Tet1 were upregulated, accompanied by increased histone acetylation and reduced DNA methylation at the Bcl11b promoter, enhancing RNA polymerase II recruitment and Bcl11b transcription. NAT8F7 and TET1 additively increased Bcl11b transcription and P1NP production in C2C12 cells. Similar molecular changes occurred during DSS-induced colitis and were reversed by healthy FMT. BCL11B overexpression promoted myoblast proliferation and collagen production. In conclusion, DM promotes cardiac fibrosis through epigenetic activation of Bcl11b , revealing a novel gut–heart axis. Healthy FMT mitigates these effects, highlighting microbiome-targeted strategies for IBD-associated cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Ou et al. (2026) studied Colitis-associated gut dysbiosis and profibrotic cardiac remodeling. Dysbiotic microbiome transplantation (from Il10-/- mice) or DSS-induced colitis with or without healthy fecal microbiota transplantation (FMT) vs. Normal microbiome transplantation from wild-type donors or healthy control FMT was evaluated on Cardiac contractility, collagen deposition, and epigenetic activation of Bcl11b. Dysbiotic microbiome transplantation impaired cardiac contractility and promoted cardiac fibrosis via Nat8f7- and Tet1-mediated epigenetic activation of Bcl11b, which was reversed by healthy FMT.
Synapse has enriched 10 related papers. Consider them for comparative context: